Evidence map›Paper›PMID 35868222›Full record

ArticleNeuroImage. Clinical2022

In-depth characterization of neuroradiological findings in a large sample of individuals with autism spectrum disorder and controls.

Sara Ambrosino, Hasnaa Elbendary, Maarten Lequin, Dominique Rijkelijkhuizen, Tobias Banaschewski, Simon Baron-Cohen, Nico Bast, Sarah Baumeister, Jan Buitelaar, Tony Charman and 15 more

Open access · goldAbstract read
In one paragraph

Article in NeuroImage. Clinical, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
1.3field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 11 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors at 12 institutions in 9 countries.

Sara AmbrosinoUniversity Medical Center Utrecht, Utrecht, the Netherlands. Electronic address: S.AmbrosinodiBruttopilo-3@umcutrecht.nl.
Hasnaa ElbendaryClinical Genetics Department, Human Genetics and Genome Research Division of the National Research Center, Cairo, Egypt.
Maarten LequinDepartment of Radiology, University Medical Center Utrecht, Utrecht, the Netherlands.
Dominique RijkelijkhuizenUniversity Medical Center Utrecht, Utrecht, the Netherlands; Department of Cognitive Neuroscience, Donders Institute for Brain, Cognition and Behaviour, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands.
Tobias BanaschewskiDepartment of Child and Adolescent Psychiatry, Central Institute of Mental Health, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.
Simon Baron-CohenAutism Research Centre, Department of Psychiatry, University of Cambridge, Cambridge, United Kingdom.
Nico BastDepartment of Child and Adolescent Psychiatry, Central Institute of Mental Health, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.
Sarah BaumeisterDepartment of Child and Adolescent Psychiatry, Central Institute of Mental Health, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.
Jan BuitelaarDepartment of Cognitive Neuroscience, Donders Institute for Brain, Cognition and Behaviour, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands.
Tony CharmanDepartment of Psychology, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, United Kingdom.
Daisy CrawleyDepartment of Forensic and Neurodevelopmental Sciences, Institute of Psychiatry, Psychology & Neuroscience, King's College, London, United Kingdom.
Flavio Dell'AcquaDepartment of Forensic and Neurodevelopmental Sciences, Institute of Psychiatry, Psychology & Neuroscience, King's College, London, United Kingdom.
Hannah HaywardDepartment of Forensic and Neurodevelopmental Sciences, Institute of Psychiatry, Psychology & Neuroscience, King's College, London, United Kingdom.
Rosemary HoltAutism Research Centre, Department of Psychiatry, University of Cambridge, Cambridge, United Kingdom.
Carolin MoessnangDepartment of Psychiatry and Psychotherapy, Central Institute of Mental Health, University of Heidelberg, Mannheim, Germany.
Antonio M PersicoChild and Adolescent Neuropsychiatry Program at Modena University Hospital, & Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Modena, Italy; Child Neuropsychiatry / Neurodevelopmental Disorders Unit, University "Campus Bio-Medico", Rome, Italy.
Roberto SaccoChild Neuropsychiatry / Neurodevelopmental Disorders Unit, University "Campus Bio-Medico", Rome, Italy.
Antonia San José CáceresDepartment of Forensic and Neurodevelopmental Sciences, Institute of Psychiatry, Psychology & Neuroscience, King's College, London, United Kingdom; Instituto de Investigación Sanitaria Gregorio Marañón (IISGM), Madrid and CIBERSAM (Centro Investigación Biomédica en Red Salud Mental), Spain.
Julian TillmannRoche Pharma Research and Early Development, Neuroscience and Rare Diseases, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Basel, Switzerland.
EU-AIMS LEAP Group
Eva LothDepartment of Forensic and Neurodevelopmental Sciences, Institute of Psychiatry, Psychology & Neuroscience, King's College, London, United Kingdom.
Christine EckerDepartment of Forensic and Neurodevelopmental Sciences, Institute of Psychiatry, Psychology & Neuroscience, King's College, London, United Kingdom; Department of Child and Adolescent Psychiatry, University Hospital, Goethe University, Frankfurt am Main, Germany.
Bob OranjeCenter for Neuropsychiatric Schizophrenia Research (CNSR) and Center for Clinical Intervention and Neuropsychiatric Schizophrenia Research (CINS), Mental Health Centre Glostrup, University of Copenhagen, Glostrup, Denmark.
Declan MurphyDepartment of Forensic and Neurodevelopmental Sciences, Institute of Psychiatry, Psychology & Neuroscience, King's College, London, United Kingdom.
Sarah DurstonUniversity Medical Center Utrecht, Utrecht, the Netherlands.
King's College London · GBHeidelberg University · DERadboud University Nijmegen · NLUniversity of Cambridge · GBGoethe University Frankfurt · DENational Water Research Center · EGRoche (Switzerland) · CHUniversità Campus Bio-Medico · ITUniversity Medical Center Utrecht · NLUniversity of Copenhagen · DKUniversity of Modena and Reggio Emilia · ITUtrecht University · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAutism spectrum disorder (ASD) is a group of neurodevelopmental conditions associated with quantitative differences in cortical and subcortical brain morphometry. Qualitative assessment of brain morphology provides complementary information on the possible underlying neurobiology. Studies of neuroradiological findings in ASD have rendered mixed results, and await robust replication in a sizable and independent sample.

methodsWe systematically and comprehensively assessed neuroradiological findings in a large cohort of participants with ASD and age-matched controls (total N = 620, 348 ASD and 272 controls), including 70 participants with intellectual disability (47 ASD, 23 controls). We developed a comprehensive scoring system, augmented by standardized biometric measures.

resultsThere was a higher incidence of neuroradiological findings in individuals with ASD (89.4 %) compared to controls (83.8 %, p = .042). Certain findings were also more common in ASD, in particular opercular abnormalities (OR 1.9, 95 % CI 1.3-3.6) and mega cisterna magna (OR 2.4, 95 % CI 1.4-4.0) reached significance when using FDR, whereas increases in macrocephaly (OR 2.0, 95 % CI 1.2-3.2), cranial deformities (OR 2.4, 95 % CI: 1.0-5.8), calvarian / dural thickening (OR 1.5, 95 % CI 1.0-2.3), ventriculomegaly (OR 3.4, 95 % CI 1.3-9.2), and hypoplasia of the corpus callosum (OR 2.7, 95 % CI 1.1-6.3) did not survive this correction. Furthermore, neuroradiological findings were more likely to occur in isolation in controls, whereas they clustered more frequently in ASD. The incidence of neuroradiological findings was higher in individuals with mild intellectual disability (95.7 %), irrespective of ASD diagnosis.

conclusionThere was a subtly higher prevalence of neuroradiological findings in ASD, which did not appear to be specific to the condition. Individual findings or clusters of findings may point towards the neurodevelopmental mechanisms involved in individual cases. As such, clinical MRI assessments may be useful to guide further etiopathological (genetic) investigations, and are potentially valuable to fundamental ASD research.

Indexed as

Autism Spectrum DisorderIntellectual DisabilityBrainCorpus CallosumHumansMagnetic Resonance ImagingASDBrain structural MRIRadiological assessment

Identifiers

PMID35868222
PMCPMC9421485
OpenAlexW4285602597

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.